Patients with BRAF V600E-mutated metastatic colorectal cancer experienced improved responses when treated with Braftovi plus Erbitux and mFOLFOX6.
Treatment with Tafinlar in combination with Mekinist showed what researchers described as “considerable efficacy” among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback